Education
About Us
Working with TipRanks
Follow Us
Conduit Pharmaceuticals (CDT)
NASDAQ:CDT
Conduit Pharmaceuticals (CDT) Ownership Overview
8.36% Insiders
0.68% Mutual Funds
0.07% Other Institutional Investors
0.49% ETFs
90.40% Public Companies and
Individual Investors
The ownership structure of Conduit Pharmaceuticals (CDT) stock is a mix of institutional, retail, and individual investors. Approximately 1.23% of the company’s stock is owned by Institutional Investors, 8.36% is owned by Insiders, and 90.40% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 07, 2024 | Nirland Limited >10% Owner | xxxxxxxxxxxxx | $380800 |
| Oct 02, 2024 | Nirland Limited >10% Owner | xxxxxxxxxxxxx | $292836 |
| Sep 19, 2024 | Andrew Regan Director, >10% Owner | xxxxxxxxxxxxx | $4487011 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $123 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,958,287 | Insider | 62.85% | 3,224,533 | |
| 351,510 | Insider | 7.47% | 383,146 | |
| 341,594 | Insider | 7.26% | 372,337 | |
| 244,277 | Insider | 5.19% | 266,262 | |
| 236,725 | Institution | 5.03% | 258,030 | |
| 137,499 | Institution | 2.92% | 149,874 | |
| 128,314 | Institution | 2.73% | 139,862 | |
| 102,299 | Institution | 2.17% | 111,506 | |
| 53,111 | Institution | 1.13% | 57,891 | |
| 37,272 | Insider | 0.79% | 40,626 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 236,725 | Institution | 5.03% | 258,030 | |
| 137,499 | Institution | 2.92% | 149,874 | |
| 128,314 | Institution | 2.73% | 139,862 | |
| 53,111 | Institution | 1.13% | 57,891 | |
| 3,284 | Institution | 0.07% | 3,580 | |
| 327 | Institution | <0.01% | 356 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 101,207 | Institution | 2.15% | 110,316 | |
| 2,029 | Institution | 0.04% | 2,435 | |
| 1,129 | Institution | 0.02% | 1,355 | |
| 1,092 | Institution | 0.02% | 1,190 | |
| 134 | Institution | <0.01% | 161 | |
| 95 | Institution | <0.01% | 96 | |
| 78 | Institution | <0.01% | 193 | |
| 10 | Institution | <0.01% | 11 | |
| 1 | Institution | <0.01% | 1 |
FAQ
Who Owns Conduit Pharmaceuticals (CDT)?
According to the latest TipRanks data, approximately 0.07% of the company's stock is held by institutional investors, 8.36% is held by insiders, and 90.40% is held by retail investors.
What percentage of Conduit Pharmaceuticals (CDT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.07% of Conduit Pharmaceuticals (CDT) stock is held by institutional investors.
What percentage of Conduit Pharmaceuticals (CDT) stock is held by retail investors?
According to the latest TipRanks data, approximately 90.40% of Conduit Pharmaceuticals (CDT) stock is held by retail investors.
Who owns the most shares of Conduit Pharmaceuticals (CDT)?
Freda Lewis-Hall owns the most shares of Conduit Pharmaceuticals (CDT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.